Answers are grounded in this paper and cite their sources.
GDF5 encodes growth differentiation factor 5 which regulates bone and cartilage formation by the BMP signaling pathway. Brachydactyly type C (BDC), Du Pan syndrome (DPS) and acromesomelic dysplasia 2A (AMD2A) are distinct types of skeletal dysplasias caused by GDF5 variants. They are listed in ascending order of severity of skeletal phenotype, but the genotype-phenotype association remains unclear. Here, we reported a three-generation family with two GDF5 variants, c·1129C > T (p.Arg377Trp) and c·487C > T (p.Arg163Cys). c·1129C > T is known as a recurrent variant for AMD2A in homozygotes. In our family, two individuals with DPS are compound heterozygotes for c·1129C > T and c·487C > T, while six individuals with BDC are heterozygotes for c·1129C > T. In contrast, two individuals with heterozygous c·487C > T are normal. A protein structural analysis followed by a functional assay on the BMP signaling indicated that both c·1129C > T and c·487C > T led to loss of function of GDF5 . Our study provides a unique example, in which different types of genotypic combination of two GDF5 variants are associated with different GDF5 -related disorders, suggesting that the remaining GDF5 function decides a range of skeletal phenotypes including BDC, DPS and AMD2A by a dose-dependent way.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: